UnitedHealth Group Incorporated (UNH)
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's Why UnitedHealth Group (UNH) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Will UnitedHealth (UNH) Gain on Rising Earnings Estimates?
UnitedHealth Group (UNH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
All You Need to Know About UnitedHealth (UNH) Rating Upgrade to Strong Buy
UnitedHealth (UNH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
UnitedHealth: The Cure For The AI Blues
UnitedHealth Group remains a Buy after a strong Q2, with robust earnings, raised guidance, and a doubled buyback authorization. UNH benefits from the market rotation out of AI and into defensive healthcare, positioning it as a sector leader. AI investments at UNH focus on margin expansion through operational efficiency, not speculative growth, leveraging its vast data assets.
UnitedHealth Group (UNH) is a Great Momentum Stock: Should You Buy?
Does UnitedHealth Group (UNH) have what it takes to be a top stock pick for momentum investors? Let's find out.
UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
UNH lifts its 2026 outlook as Medicare and Optum improve, while commercial cost pressures delay margin recovery and keep management focused on execution.
UnitedHealth's AI Bet Paid Off. Now It Is Selling the Playbook
Every claim UnitedHealth processes, every prior authorization it reviews and every patient interaction it handles now runs through artificial intelligence (AI). The company is turning that internal overhaul into a commercial product line.
UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)
UnitedHealth Group Incorporated delivered a strong Q2, with improved medical care ratio and operating income up 50% YoY, signaling effective cost initiatives. UNH raised FY 2026 EPS guidance to $19.5–$20, reflecting operational recovery and solid cash flow prospects, especially from Optum's AI-driven growth. Despite operational improvements, UNH's valuation now trades above its 5-year average P/E, reducing risk-reward asymmetry and margin of safety.
UnitedHealth Stock Hits 2026 High on Strong Earnings, Rosy Outlook
Shares of UnitedHealth Group jumped to their highest level in more than a year Thursday after the health care and insurance giant announced results that handily topped Wall Street expectations.
UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
UNH beats Q2 earnings estimates on lower medical costs and stronger Optum Insight, then raises its 2026 EPS and cash flow outlook.
UnitedHealth Group Incorporated (UNH) Q2 2026 Earnings Call Transcript
UnitedHealth Group Incorporated (UNH) Q2 2026 Earnings Call Transcript
